Riva-fluoxetine 10 Mg Capsule; May Exceed The Interim Acceptable Intake Limit For N-nitroso-fluoxetine
RIVA-Fluoxetine 10 mg capsules are being recalled in Canada because they may contain higher levels of a potentially harmful impurity called N-nitroso-fluoxetine than what is considered acceptable. This is a Class I recall, which means there is a serious health risk. The affected product was distributed across Canada.
- Product
- RIVA-Fluoxetine 10 mg capsule
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-07-03
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/593ff1ab-9bbc-41d2-ad64-274991b35c97